Bicycle Therapeutics PLC

BCYC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001761612

SEC filings (opens in a new tab)

No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Bicycle Therapeutics PLC changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of BCYC: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Q2 2024	Change
Holders	95	107	+12
Shares	30.5M	39.7M	+9.23M (+30.3%)
Value	$759.1M	$804.0M	+$44.8M (+5.9%)

New holders (26)

Institutions that held Bicycle Therapeutics PLC at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to BCYC in Q2 2024
Institution	Shares	Value	% of portfolio
FCPM III Services B.V.	2,122,892	$43.0M	6.34%
Fairmount Funds Management LLC	1,069,199	$21.6M	2.44%
EcoR1 Capital, LLC	910,000	$18.4M	0.56%
Avoro Capital Advisors LLC	700,000	$14.2M	0.19%
Woodline Partners LP	586,622	$11.9M	0.11%
Perceptive Advisors LLC	572,000	$11.6M	0.28%
Aquilo Capital Management, LLC	156,692	$3.17M	3.06%
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)	125,283	$2.54M	0.06%
Marshall Wace, LLP	88,987	$1.80M	0.00%
Millennium Management LLC	37,507	$759.1K	0.00%
Jump Financial, LLC	28,972	$586.4K	0.01%
Nan Fung Group Holdings Ltd	17,300	$350.2K	0.37%
Dymon Asia Capital (Singapore) Pte. Ltd.	15,000	$303.6K	0.38%
Natixis Advisors, L.P.	12,912	$261.0K	0.00%
XTX Topco Ltd	10,177	$206.0K	0.02%
Aquatic Capital Management LLC	5,500	$111.3K	0.00%
Mirae Asset Global Investments Co., Ltd.	1,072	$21.7K	0.00%
Coppell Advisory Solutions LLC	1,076	$15.0K	0.00%
Manchester Capital Management LLC	450	$9.11K	0.00%
Ronald Blue Trust, Inc.	323	$8.04K	0.00%
Winch Advisory Services, LLC	172	$3.48K	0.00%
Jones Financial Companies LLLP	100	$2.02K	0.00%
Federation des caisses Desjardins du Quebec	61	$1.24K	0.00%
Bell Investment Advisors, Inc	22	$446	0.00%
Caitlin John, LLC	14	$283	0.00%
Mather Group, LLC.	5	$125	0.00%

Sold out (14)

Institutions that held Bicycle Therapeutics PLC at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of BCYC in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Paradigm Biocapital Advisors LP	3,246,759	$80.8M
Suvretta Capital Management, LLC	914,476	$22.8M
Trexquant Investment LP	92,552	$2.30M
Concurrent Investment Advisors, LLC	21,799	$542.8K
ADAR1 Capital Management, LLC	14,430	$359.3K
Danske Bank A/S	13,330	$331.9K
Fishman Jay A Ltd	9,000	$224.1K
PDS Planning, Inc	8,450	$210.4K
Leonteq Securities AG	5,000	$124.5K
First Manhattan Co	2,200	$54.8K
US Bancorp	300	$7.47K
Group One Trading, L.P.	91	$2.27K
Northwestern Mutual Wealth Management Co	5	$125
Zurcher Kantonalbank (Zurich Cantonalbank)	4	$100